Clergue F, Auroy Y, Pequignot F, Jougla E, Lienhart A, Laxenaire M-C. Evolution of the anaesthetic workload--the French experience. Best Pract Res Clin Anaesthesiol. 2002 Sep;16(3):459–73.
Hoffmann R, Plug I, Khoshaba B, McKee M, Mackenbach JP, AMIEHS working group. Amenable mortality revisited: the AMIEHS study. Gac Sanit. 2013 Jun;27(3):199–206.
Menvielle G, Rey G, Jougla E, Luce D. Diverging trends in educational inequalities in cancer mortality between men and women in the 2000s in France. BMC Public Health. 2013 Sep 10;13(1):823.
Hoffmann R, Plug I, McKee M, Khoshaba B, Westerling R, Looman C, et al. Innovations in health care and mortality trends from five cancers in seven European countries between 1970 and 2005. Int J Public Health. 2013 Aug 29;
Hoffmann R, Plug I, McKee M, Khoshaba B, Westerling R, Looman C, et al. Innovations in medical care and mortality trends from four circulatory diseases between 1970 and 2005. Eur J Public Health. 2013 Oct;23(5):852–7.
Marijon E, Tafflet M, Antero-Jacquemin J, El Helou N, Berthelot G, Celermajer DS, et al. Mortality of French participants in the Tour de France (1947-2012). Eur Heart J. 2013 Oct;34(40):3145–50.
Rafnsson SB, Bhopal RS, Agyemang C, Fagot-Campagna A, Harding S, Hammar N, et al. Sizable variations in circulatory disease mortality by region and country of birth in six European countries. Eur J Public Health. 2013 Aug;23(4):594–605.
Ghosn W, Kassie D, Jougla E, Rican S, Rey G. Spatial interactions between urban areas and cause-specific mortality differentials in France. Health Place. 2013 Nov;24:234–41.
Ghosn W, Kassié D, Jougla E, Salem G, Rey G, Rican S. Trends in geographic mortality inequalities and their association with population changes in France, 1975-2006. Eur J Public Health. 2013 Oct;23(5):834–40.
Mackenbach JP, Hoffmann R, Khoshaba B, Plug I, Rey G, Westerling R, et al. Using “amenable mortality” as indicator of healthcare effectiveness in international comparisons: results of a validation study. J Epidemiol Community Health. 2013 Feb;67(2):139–46.
Mertes PM, Alla F, Tréchot P, Auroy Y, Jougla E, Groupe d’Etudes des Réactions Anaphylactoïdes Peranesthésiques. Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol. 2011 Aug;128(2):366–73.
Zatoński WA, HEM project team. Epidemiological analysis of health situation development in Europe and its causes until 1990. Ann Agric Environ Med. 2011 Dec;18(2):194–202.
Bouillon K, Haddy N, Delaloge S, Garbay J-R, Garsi J-P, Brindel P, et al. Long-term cardiovascular mortality after radiotherapy for breast cancer. J Am Coll Cardiol. 2011 Jan 25;57(4):445–52.
Rogel A, Belot A, Suzan F, Bossard N, Boussac M, Arveux P, et al. Reliability of recording uterine cancer in death certification in France and age-specific proportions of deaths from cervix and corpus uteri. Cancer Epidemiol. 2011 Jun;35(3):243–9.
Bouvier A-M, Remontet L, Jougla E, Launoy G, Grosclaude P, Buémi A, et al. Incidence of gastrointestinal cancers in France. Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 1):877–81.
Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, et al. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer. 2004 Jul 15;101(2):317–24.
Lewden C, May T, Rosenthal E, Burty C, Bonnet F, Costagliola D, et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: The “Mortalité 2000 and 2005” surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):590–8.
Marcellin P, Pequignot F, Delarocque-Astagneau E, Zarski J-P, Ganne N, Hillon P, et al. Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption. J Hepatol. 2008 Feb;48(2):200–7.
Ziadé N, Jougla E, Coste J. Population-level influence of rheumatoid arthritis on mortality and recent trends: a multiple cause-of-death analysis in France, 1970-2002. J Rheumatol. 2008 Oct;35(10):1950–7.
Romon I, Jougla E, Balkau B, Fagot-Campagna A. The burden of diabetes-related mortality in France in 2002: an analysis using both underlying and multiple causes of death. Eur J Epidemiol. 2008;23(5):327–34.
Kernéis S, Boëlle P-Y, Grais RF, Pavillon G, Jougla E, Flahault A, et al. Mortality trends in systemic sclerosis in France and USA, 1980-1998: an age-period-cohort analysis. Eur J Epidemiol. 2010;25(1):55–61.
Ziadé N, Jougla E, Coste J. Population-level impact of osteoporotic fractures on mortality and trends over time: a nationwide analysis of vital statistics for France, 1968-2004. Am J Epidemiol. 2010 Oct 15;172(8):942–51.
Béjot Y, Aouba A, de Peretti C, Grimaud O, Aboa-Eboulé C, Chin F, et al. Time trends in hospital-referred stroke and transient ischemic attack: results of a 7-year nationwide survey in France. Cerebrovasc Dis. 2010;30(4):346–54.
Benhamou D, Lienhart A, Auroy Y, Péquignot F, Jougla E. Accidents by ABO incompatibility and other main complications related to blood transfusion in surgical patients: data from the French national survey on anaesthesia-related deaths. Transfus Clin Biol. 2005 Nov;12(5):389–90.
Salmon-Ceron D, Lewden C, Morlat P, Bévilacqua S, Jougla E, Bonnet F, et al. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol. 2005 Jun;42(6):799–805.
Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, et al. Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France. Scand J Infect Dis. 2005;37(6–7):482–7.